Career Development Program
职业发展计划
基本信息
- 批准号:9546619
- 负责人:
- 金额:$ 10.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdvertisementsAfrican AmericanAttentionAwardBasic ScienceBiologyBrainBrain NeoplasmsCancer CenterClinicalClinical SciencesCommunitiesDataDevelopmentDiagnosisEducationEnsureEvaluationEvolutionFacultyFeedbackFundingGrantHistorically Black Colleges and UniversitiesInstitutesInstitutionJournalsK-Series Research Career ProgramsLeadershipLearning SkillMalignant NeoplasmsMalignant neoplasm of brainMathematicsMedicalMedical StudentsMedical centerMedicineMentorsMentorshipMinorityMinority RecruitmentNorth CarolinaPeer ReviewPersonnel ManagementPositioning AttributePreventionProbabilityProgram DevelopmentProgress ReportsResearchResearch PersonnelResearch Project GrantsScienceScientistSeedsSourceTalentsTeacher Professional DevelopmentTechnologyTestingTrainingTranslational ResearchUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesUpdateWomanWritingcareercareer developmentinterestmedical schoolsmeetingsmemberminority investigatorneuro-oncologynovelnovel strategiespeerpost-doctoral trainingprofessorprogramsrecruitsuccess
项目摘要
The Career Development Program (CDP) is a critical and integral component of the Duke SPORE in
Brain Cancer that facilitates the identification, support, and mentoring of promising new and early-stage
investigators in translational neuro-oncology. Projects will be encouraged to be broadly collaborative and to
test novel paradigms that will further expand the scope of the brain tumor diagnosis, prevention, and
management. The DRP will specifically target projects having a strong likelihood of becoming successful and
independent research projects or having a high potential of developing into full SPORE projects that replace
projects within the SPORE that are not progressing satisfactorily. The Specific Aims of the CDP are to:
1) Identify and support meritorious translational projects led by NIH-designated new or early stage
investigators that have a high probability of impacting the diagnosis, treatment or prevention of
brain tumors;
2) Recruit and retain promising women and minority new and early-stage investigators with a
career focus in translational neuro-oncology research;
3) Facilitate access to programs for leadership training and a highly successful program for grant
writing that includes mentoring of early-stage and new investigators to enable such faculty
members to achieve independent faculty status with emphasis on neuro-oncology research; and
4) Provide continuing evaluation of progress on funded projects and facilitate their evolution into
full SPORE projects or independently funded projects.
This application builds upon the highly successful CDP of the previous Duke Brain Cancer SPORE that
resulted in the successful development of several early-stage scientists, including a number of women and
minority investigators. This application builds upon and extends this success through the integration of the
SPORE CDP with a highly advanced faculty development program, which offers a wide range of short courses
to enable young faculty to learn skills related to leadership, scientific writing, personnel management, grants
management and others. This integration of the CDP with the Office of Faculty Development will ensure
longitudinal mentorship and development of CDP award recipients throughout their tenure at our medical
center. We anticipate the successful recruitment of outstanding new talent to the field of neuro-oncology
research, as we have done in the past, through this highly visible awards program.
职业发展计划(CDP)是杜克孢子的关键组成部分
脑癌促进有希望的新和早期的识别,支持和指导
翻译神经肿瘤学研究人员。鼓励项目广泛合作,并
测试新型范例,将进一步扩大脑肿瘤诊断,预防和
管理。 DRP将专门针对具有成功的可能性的项目,并且
独立的研究项目或具有较高的孢子项目的潜力,以取代
孢子中没有令人满意的项目。 CDP的具体目的是:
1)识别和支持由NIH指定的新阶段或早期阶段领导的有功翻译项目
影响诊断,治疗或预防的可能性很高的研究者
脑肿瘤;
2)招募和保留有前途的妇女和少数族裔新的和早期的调查员
翻译神经肿瘤研究的职业重点;
3)促进获得领导培训计划的访问,并为格兰特提供了非常成功的计划
写作包括指导早期和新调查人员以启用此类教师
成员在强调神经肿瘤研究的重点下获得独立的教师身份;和
4)提供对资金项目的进度的持续评估,并促进其发展为
完整的孢子项目或独立资助的项目。
该应用基于以前的杜克脑癌孢子的非常成功的CDP
导致了几位早期科学家的成功发展,包括许多妇女和
少数派研究人员。该应用程序建立并通过集成
带有高级教师开发计划的孢子CDP,提供各种短课程
使年轻教师能够学习与领导力,科学写作,人事管理,赠款有关的技能
管理和其他人。 CDP与教师发展办公室的这种整合将确保
在我们的医学任职期间,CDP奖励获得者的纵向指导和发展
中心。我们预计神经肿瘤学领域将成功招募杰出的新人才
像过去一样,通过这个高度可见的奖励计划进行了研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M. Ashley其他文献
Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas.
卡铂 (CBDCA) 在进行性低级别胶质瘤中的 II 期研究。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:4.1
- 作者:
Albert Moghrabi;Henry S Friedman;David M. Ashley;K. Bottom;T. Kerby;Elizabeth A. Stewart;Carol S. Bruggers;James M. Provenzale;Martin A. Champagne;Linda Hershon;M. Watral;Janis Ryan;Karima Rasheed;Shelley Lovell;David N. Korones;Herbert E. Fuchs;Timothy M George;R. McLendon;A. Friedman;Edward G. Buckley;D. Longee - 通讯作者:
D. Longee
The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases
儿童多形性黄色星形细胞瘤15例组织学演变
- DOI:
10.1097/pat.0b013e328340bb98 - 发表时间:
2011 - 期刊:
- 影响因子:4.5
- 作者:
Xiangru Wu;P. Bandopadhayay;J. Ng;David M. Ashley;C. Chow - 通讯作者:
C. Chow
General anaesthesia or conscious sedation for painful procedures in childhood cancer: the family‘s perspective
全身麻醉或清醒镇静治疗儿童癌症的痛苦手术:家人的观点
- DOI:
10.1136/adc.88.3.253 - 发表时间:
2003 - 期刊:
- 影响因子:5.2
- 作者:
C. Crock;C. Olsson;R. Phillips;G. Chalkiadis;S. Sawyer;David M. Ashley;S. Camilleri;J. Carlin;P. Monagle - 通讯作者:
P. Monagle
Brain stem gliomas: Patterns of Care in Victoria from 1998–2000
- DOI:
10.1016/j.jocn.2007.04.008 - 发表时间:
2008-03-01 - 期刊:
- 影响因子:
- 作者:
Mark A. Rosenthal;David M. Ashley;Katharine J. Drummond;Michael Dally;Michael Murphy;Lawrence Cher;Vicky Thursfield;Graham G. Giles - 通讯作者:
Graham G. Giles
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
STING 激动剂 8803 重新编程免疫微环境并提高胶质母细胞瘤临床前模型的存活率
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:15.9
- 作者:
Hinda Najem;S. Lea;Shashwat Tripathi;Lisa Hurley;Chao;Ivana William;Moloud Sooreshjani;Michelle Bowie;Genevieve Hartley;Corey Dussold;Sebastian Pacheco;C. Dmello;Catalina Lee;Kathleen McCortney;Alicia Steffens;Jordain Walshon;Martina Ott;Jun Wei;Anantha L. Marisetty;I. Balyasnikova;R. Stupp;R. Lukas;Jian Hu;C. D. James;C. Horbinski;Maciej S. Lesniak;David M. Ashley;Waldemar Priebe;Leonidas C. Platanias;Michael A. Curran;Amy B. Heimberger - 通讯作者:
Amy B. Heimberger
David M. Ashley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M. Ashley', 18)}}的其他基金
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
ATRX 突变、先天免疫激活和恶性胶质瘤的治疗脆弱性
- 批准号:
10375084 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
ATRX 突变、先天免疫激活和恶性胶质瘤的治疗脆弱性
- 批准号:
10666347 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10488242 - 财政年份:2021
- 资助金额:
$ 10.7万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10488237 - 财政年份:2021
- 资助金额:
$ 10.7万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10305565 - 财政年份:2021
- 资助金额:
$ 10.7万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10305568 - 财政年份:2021
- 资助金额:
$ 10.7万 - 项目类别:
Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?
低肿瘤突变负荷是否可以预测复发性胶质母细胞瘤对溶瘤脊髓灰质炎病毒治疗的反应?
- 批准号:
9807277 - 财政年份:2019
- 资助金额:
$ 10.7万 - 项目类别:
相似海外基金
The SRBR 2022 Meeting: Rhythms of Life - from Molecules to Policy
SRBR 2022 会议:生命的节奏 - 从分子到政策
- 批准号:
10467738 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
Understanding Tobacco Treatment Refusal Among African-Americans in the Context of Lung Cancer Screening
了解肺癌筛查背景下非裔美国人拒绝烟草治疗的情况
- 批准号:
9905136 - 财政年份:2016
- 资助金额:
$ 10.7万 - 项目类别:
The Effect of Food Marketing and Attentional Biases on Eating behaviors in the African American Adolescent Girls
食品营销和注意力偏差对非裔美国少女饮食行为的影响
- 批准号:
9126868 - 财政年份:2016
- 资助金额:
$ 10.7万 - 项目类别: